Showing posts with label Type 1 Diabetes. Show all posts
Showing posts with label Type 1 Diabetes. Show all posts

Feb 17, 2016

How Insulin Changed the Course of Medicine

The human body is remarkably efficient when it comes to managing resources—and one of the key players in this system is insulin. This essential hormone plays a critical role in conserving energy by storing nutrients when food is abundant. Excess carbohydrates are turned into glycogen and stored in the liver and muscles, fats are packed away in adipose (fat) tissue, and proteins are built from amino acids. All of this ensures that the body has energy reserves when food isn’t readily available.

While our in-depth understanding of insulin is relatively new, the health condition it’s closely linked to—diabetes—has been documented since ancient times. Early references to symptoms of diabetes appear in Egyptian and Greek texts, proving just how long this condition has affected human health.


The islets of Langerhans (shown here in a high-power magnification), located in the pancreas, are responsible for the production of insulin.

The Road to Discovery: A History of Insulin

1869: The Islets of Langerhans

The modern story of insulin begins with Paul Langerhans, a German medical student who, in 1869, identified a cluster of previously unknown cells within the pancreas. These clusters would later be named the islets of Langerhans—the very place where insulin is produced.

1889: Linking the Pancreas to Diabetes

In 1889, German scientists Joseph von Mering and Oskar Minkowski took the next big step. Curious about the pancreas, they removed the organ from a dog. The result? The dog quickly developed severe diabetic symptoms, including high sugar levels in its urine—a key indicator of diabetes. This experiment made it clear that the pancreas played a central role in blood sugar regulation.

1921: The Breakthrough That Changed Everything

Fast forward to 1921. In Canada, a determined surgeon named Frederick Banting convinced John J.R. MacLeod, a professor at the University of Toronto, to let him use his lab during summer break. With the help of Charles Best, a young student, Banting repeated the pancreas removal experiment—but this time with a twist.

They injected one of the diabetic dogs with an extract from a healthy pancreas, and to their amazement, the dog’s diabetic symptoms improved. They had just uncovered the therapeutic power of what we now call insulin.

1922: First Human Treatment

In January 1922, the experiment reached a groundbreaking milestone. Leonard Thompson, a 14-year-old boy with type 1 diabetes, became the first human to receive insulin. The treatment worked—and it marked a turning point in medical history.


Recognition, Controversy, and Commercialization

In 1923, the discovery of insulin earned Banting and MacLeod the Nobel Prize. However, the credit distribution sparked controversy. Banting believed Charles Best deserved equal recognition and shared his prize money with him. MacLeod did the same with James Collip, the biochemist who helped purify the insulin extract.

That same year, pharmaceutical company Eli Lilly began the mass production of insulin, making this life-saving hormone available to diabetic patients around the world.


The Lifesaving Impact of Insulin

Before insulin, a diagnosis of type 1 diabetes was essentially a death sentence—most patients, especially children, lived only a few months after diagnosis. Today, thanks to insulin therapy, people with well-managed diabetes can live just as long and as full lives as those without the condition.


Key Takeaways for Readers

  • Insulin is a key hormone that stores excess energy and helps maintain stable blood sugar levels.
  • Diabetes has been known for thousands of years, but its cause remained a mystery until the late 19th and early 20th centuries.
  • The discovery of insulin in 1921 revolutionized diabetes treatment, transforming a fatal disease into a manageable one.
  • Early pioneers like Banting, Best, and Collip played critical roles in making insulin therapy a global medical breakthrough.
  • Today’s diabetes management tools—from insulin pumps to glucose monitors—are built on this incredible scientific foundation.

✳️ Did you know? The first insulin treatments were made using extracts from animal pancreases. Modern insulin, however, is produced using advanced biotechnology, making it purer and more effective than ever before.

💡 Worth thinking about: What other modern diseases could be drastically changed by a breakthrough as monumental as insulin?

Dec 27, 2015

Understanding Diabetes Mellitus: A Hormonal Disorder with Genetic Roots

Diabetes mellitus is a long-term metabolic disorder that affects how your body manages blood sugar (glucose). In this condition, the body either doesn't produce enough insulin or fails to use it properly, leading to elevated glucose levels in the blood. Without proper glucose absorption, the body's cells are deprived of their main energy source and begin breaking down fats and proteins instead. Over time, this can lead to serious complications such as dehydration, cardiovascular disease, kidney failure, nerve damage, and in severe cases, gangrene.


Types of Diabetes Mellitus

Diabetes is categorized into two main types, each with distinct causes, characteristics, and treatment approaches.


Type 1 Diabetes (Insulin-Dependent)

Also known as juvenile diabetes, Type 1 diabetes typically appears in children, teens, or young adults—usually before the age of 40. It’s an autoimmune disorder, meaning the body’s own immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas.

In many cases, a viral infection may trigger this autoimmune response. With beta cells damaged, the pancreas cannot produce enough insulin, and glucose builds up in the blood instead of entering cells. People with Type 1 diabetes require lifelong insulin therapy, usually delivered via injections.

Genetic Insight:

The gene responsible for insulin production is found on chromosome 11. Variations and polymorphisms in this region are linked to a higher risk of developing Type 1 diabetes. It’s considered a polygenic disorder, meaning multiple genes and environmental factors play a role in its development.


Type 2 Diabetes (Non-Insulin Dependent)

Type 2 diabetes is the most common form, accounting for 90% of all diabetes cases. Unlike Type 1, people with this type produce insulin, but their body cells don’t respond to it effectively—a condition known as insulin resistance.

Type 2 diabetes usually appears after the age of 40, though it can develop earlier in people with risk factors like obesity, sedentary lifestyle, and family history. It is typically managed through diet, exercise, and weight control. A high-fiber, low-fat, and low-sodium diet is often recommended.

Genetic Insight:

There is a strong hereditary link in Type 2 diabetes. Some individuals carry genes that impair insulin receptor function or affect glucose metabolism. A subtype called Maturity-Onset Diabetes of the Young (MODY) appears before age 25 and is often passed down as an autosomal dominant trait. In many MODY cases, a mutation in the glucokinase gene—which normally converts glucose to glucose-6-phosphate in the pancreas—is responsible. Mutations in other genes that control pancreatic development and insulin regulation can also contribute to early-onset forms of the disease.


Key Takeaways for Readers

  • Diabetes mellitus disrupts how the body uses glucose, leading to energy deficits in cells and long-term health risks.
  • Type 1 diabetes is autoimmune, often starting early in life and requiring daily insulin support.
  • Type 2 diabetes is linked to insulin resistance and lifestyle factors, commonly appearing in adults but increasingly seen in younger individuals.
  • Genetics play a major role in both types, influencing how the disease starts and progresses.
  • Managing Type 2 diabetes early through diet, exercise, and weight loss can significantly reduce risks and improve quality of life.
  • New research continues to reveal how specific genes contribute to diabetes, opening doors for personalized treatment and early detection.